AI assistant
Zealand Pharma Director's Dealing 2020
3391_rpt_2020-04-08_b8e56e40-6081-45ed-92e0-69f1ff547974.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Adam Steensberg | ||
| 2. | Reason for the notification | |||
| a) | Position/status | EVP, Chief Medical and Development Officer in Zealand Pharma A/S | ||
| b) | Initial notification/Amend ment |
Initial notification | ||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||
| a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
||
| b) | LEI1 | 549300ITBB1ULBL4CZ12 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instru ment |
Shares | ||
| Identification code | DK0060257814 | |||
| b) | Nature of the transaction | Sale of shares |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 219,7 | 26.764 | |||
| d) | Aggregated information - Aggregated volume - Price |
DKK 5.881.311,67 | ||
| e) | Date of the transaction | 06 April 2020 |
||
| f) | Place of the transaction | Nasdaq Copenhagen A/S |